Embedding a Senior Consultant to Rebuild a Deviation Program at a High-Growth Biologics Site
How staff augmentation helped a biologics manufacturer move from reactive firefighting to structured deviation management.
We recently published an explainer on how embedding a QA consultant can be a more attractive alternative to hiring an FTE for a long-term project need. Today, we’re publishing the companion piece to that: a real-world case study of that model in action.
Here’s a look at what staff augmentation actually looks like in practice:
About two years ago, a biologics manufacturing facility was scaling production to meet surging demand. New personnel were coming on fast, but the training and oversight to support that growth weren’t keeping pace. The deviation log swelled to 80 open events. Extensions started piling up, and regulators took notice.
It’s a pattern we see regularly across the industry, and the path back to control often requires dedicated, experienced resources that the internal team simply doesn’t have bandwidth to provide.
The problem
The biologics facility was struggling with its deviation program. The site was an older facility that had changed hands multiple times and was now manufacturing injectable products. The increase in production brought in a wave of new floor personnel, but again, the Quality infrastructure didn’t keep pace.
By the time the firm acknowledged it had a problem, the deviation log had ballooned to roughly 80 open deviations at any given time, with more opening almost daily. Extensions were common, creating a backlog that was compounding.
The volume and extensions had drawn the attention of regulatory authorities. There were no warning letters or official sanctions, but the message was clear: you have too many open deviations and too many extensions. Get this under control.
What was driving the problem
The deviation backlog, we came to learn, was the product of several systemic problems reinforcing each other:
Training was inadequate. The facility had expanded production and brought in a large number of new manufacturing personnel, but the training had not kept up. Staff were creating avoidable deviations because they didn’t fully understand the processes or their documentation responsibilities. Supervisors weren’t consistently present on the manufacturing floor to prevent those issues.
There weren’t enough trained deviation writers. The people who could actually investigate and write up deviations were a small group, and the workload overwhelmed them.
There was no agreed-upon process for handling deviations. No standardized timelines, no stage gates, little to no metrics, and no daily accountability. Deviations would often get opened and then sit, sometimes because the writer didn’t have the batch records or documentation needed to investigate, sometimes because no one was tracking where things stood.
Deviation management was ad hoc. Getting essential documentation (batch records, personnel interviews, photos) required individuals to chase down staff on their own, with no system for escalation or follow-up.
The combination of all of these issues created a self-reinforcing cycle: new deviations piled on top of old ones, the backlog prevented CAPAs from being initiated, and without CAPAs addressing root causes, the same problems kept generating new deviations.
Our approach and solution
The firm decided to form a dedicated deviation team: a group pulled from different parts of the organization, supplemented by external contractors, whose sole job was to attack the backlog.
Through us, they brought in a senior Quality consultant with over 30 years of experience across medical devices and pharma, including deviation management, complaint handling, root cause analysis, and regulatory operations at multiple large manufacturers.
He was writing deviations by day three, initially working on-site full-time.
As relationships deepened and he built fluency with the site’s systems, the arrangement shifted to a hybrid schedule: a few days on-site, a few days remote. The engagement ran from start to finish for nearly two years, marked by several extensions.
The work projects
Our consultant’s first priority was getting organized. The deviation program lacked basic structure, so he helped build it:
A stage gate system was established to track each deviation through defined stages: initial information gathering, classification as major or minor, investigation, peer review, QA review and approval, and closure. Each stage had specific timeframes within a 35-day target. Minor deviations were expected to be ready for QA approval by day 10. Majors by day 20. The remaining days provided a buffer for revisions.
A daily management meeting was implemented. If a deviation was on schedule, the writer didn’t need to attend. If it was behind, the writer had to report, not for punishment, but for support. The meeting’s purpose was to remove roadblocks: Do you have the batch records you need? Do you need to interview someone on the night shift? Can someone else take one of your assignments? The posture was “how can we help,” not “why aren’t you done.”
Getting the right information to deviation writers faster turned out to be one of the most consequential improvements. The consultant estimated that 10-20% of the 35-day timeline was being consumed just getting the initial documentation needed to understand what had happened. Batch records were missing. Photos were not taken. Details from the manufacturing floor were incomplete or vague. So, he put in place a system to surface these needs in the daily meeting and assign someone to deliver them, rather than leaving each writer to chase information independently.
Extensions, which had previously been granted almost automatically, now required the writer to present to the VP and senior staff with a formal explanation. Legitimate reasons, like waiting for lab results from an external facility or pending stability data, were accepted, while solvable reasons were addressed.
Manufacturing support personnel and QA were put on call on the production floor alongside manufacturing staff. When something went wrong, they were there immediately, intervening early, before a small issue became a formal deviation. This was preventive, not reactive, and it reduced the rate of new deviations entering the system.
The deviation work itself spanned the full range of issues that arise in a biologics manufacturing environment. Some were serious, such as leaks that caused contamination events requiring large-scale decontamination of the production suite.
Others were systemic: an external cleaning contractor mixing solutions to the wrong concentrations, requiring a multi-month look-back across every formulation they had handled. Or equipment calibration records that had lapsed, forcing a retrospective review of every batch manufactured since the last verified calibration, using ancillary data like conductivity and pH to confirm the product was within specification.
And many were seemingly minor, but important indicators of a need for improvement: a missed signature, a calculation error, a verifier who did not sign off. Simple to describe, but each one still consumed a day or more of a trained deviation writer’s time to properly investigate and close. They were expensive mistakes, and many were preventable with better training and floor supervision.
The results
Over the course of the engagement, the facility’s deviation posture changed materially:
The number of open deviations at any given time fell from roughly 80 to around a manageable 20. The number of extensions dropped dramatically, and those that remained were justified by legitimate external dependencies (lab results, stability studies, outside testing), not by internal delays or disorganization.
The stage gate system and daily management meeting that the consultant helped establish were adopted by senior leadership and formalized across the organization, with specific timeframes codified for each stage of the deviation lifecycle. What started as an improvised structure within the deviation team became the facility’s standard operating approach.
Manufacturing support and QA personnel on the production floor reduced the rate of new deviations being generated. CAPA implementation and follow-up improved as the deviation backlog cleared and freed up bandwidth for preventive work. The internal team had more trained deviation writers, a clearer process, and a management structure that held people accountable without creating a “punitive” culture.
The consultant outlasted several different managers during his time at the facility — a reflection of the organizational turbulence common at fast-growing companies and the stabilizing effect of having a consistent, experienced practitioner embedded in the work. Client feedback throughout the engagement was consistently positive. When the organization conducted a large-scale restructuring and released most of its contractors, he was one of the last to leave.
The takeaway
This staff augmentation engagement illustrates a situation that many manufacturers find themselves in: a quality system that was adequate at one production volume is no longer adequate at a higher one, and the internal team does not have the bandwidth or, in some cases, the specialized experience to dig out from under the deviation accumulation while also running day-to-day operations.
Bringing in an external practitioner (someone free of internal politics, institutional baggage, and organizational typecasting) provided the facility with both the technical capacity to clear the backlog and the fresh perspective to identify and address the systemic issues that created it.
Rather than “advising from the outside,” he was embedded in the operation: writing deviations, attending daily meetings, and building the relationships necessary to get things done inside a complex organization.
Critically, he also became a certified trainer and mentor to both internal staff and other contractors, transferring investigation methodologies, writing standards, and root-cause analysis techniques to on-site full-time employees. That knowledge transfer expanded the pool of capable deviation writers at the facility, directly reducing the burden on the small group of overloaded investigators who had been carrying the program before his arrival. The technical capacity he brought was immediate. The expertise he left behind was lasting.
Firms in this situation sometimes hesitate to bring in outside help because they view it as an admission of failure. In practice, it’s exactly the opposite!
Recognizing that a compounding problem requires dedicated, experienced resources (and acting on that recognition quickly) is what we see separate organizations that regain control from those that let the backlog define them.
We regularly deploy senior Quality, Regulatory, and Compliance consultants to life sciences organizations through staff augmentation engagements that integrate strategic practitioners directly into operations. To discuss whether this model fits your situation, contact our team.
Who is The FDA Group?
The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus on Quality Assurance, Regulatory Affairs, and Clinical Operations.
With thousands of resources worldwide, hundreds of whom are former FDA, we meet your precise resourcing needs through a fast, convenient talent selection process supported by a Total Quality Guarantee. Learn more and schedule a call with us to see if we’re a fit to help you access specialized professionals and execute your projects on time and on budget.